Published On: Tue, May 25th, 2021

Bal Pharma launches BALflu – generic of Covid-19 drug Favipiravir in India

Tagged with: | | | | | | | |

Bal Pharma Ltd has launched its generic of the Covid-19 drug Favipiravir under the brand name BALflu in India.

Favipiravir has been used as an anti viral drug for the treatment of patients having mild to moderate Covid-19 infection. Its formulation is available in tablets form with a strength of 400 mg.

The Covid-19 drug works by blocking and terminating viral synthesis and by inducing lethal metagenesis of influenza virus.

Bal Pharma launches BALflu – generic of Covid-19 drug Favipiravir in India

Bal Pharma launches BALflu – generic of Covid-19 drug Favipiravir in India. Image courtesy of visuals3Dde from Pixabay.

Favipiravir was approved by the (DCGI) for emergency use for Covid treatment with a recommended dosage of 1800 mg on the first day after which 800 mg has to be taken from day 2 to 14.

Shailesh Siroya – Managing Director of Bal Pharma said that the BALflu has the efficacy to clear the novel coronavirus faster by 28.7%. BALflu cost is INR 85 per tablet and can be purchased as a prescription drug.

Related posts

Leave a comment

XHTML: You can use these html tags: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>